At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SHPH Shuttle Pharmaceuticals Inc
Trading 06-26 14:59:58 EDT
0.3883
+0.0073
+1.92%
High0.3950
Low0.3700
Vol68.17K
Open0.3710
D1 Closing0.3810
Amplitude6.56%
Mkt Cap6.53M
Tradable Cap3.85M
Total Shares16.82M
T/O25.69K
T/O Rate0.69%
Tradable Shares9.93M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Shuttle Pharmaceuticals Names Timothy Lorber as Chief Financial Officer
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.